138 related articles for article (PubMed ID: 1066995)
1. Effects of normal and myasthenic serum factors on innervated and chronically denervated mammalian muscles.
Albuquerque EX; Lebeda FJ; Appel SH; Almon R; Kauffman FC; Mayer RF; Narahashi T; Yeh JZ
Ann N Y Acad Sci; 1976; 274():475-92. PubMed ID: 1066995
[No Abstract] [Full Text] [Related]
2. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
Elias SB; Appel SH
Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
[TBL] [Abstract][Full Text] [Related]
3. Interaction of myasthenic serum globulin with the acetylcholine receptor.
Almon RR; Appel SH
Biochim Biophys Acta; 1975 May; 393(1):66-77. PubMed ID: 1138925
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis as a receptor disorder.
Drachman DB; Kao I; Pestronk A; Toyka KV
Ann N Y Acad Sci; 1976; 274():226-34. PubMed ID: 786108
[No Abstract] [Full Text] [Related]
5. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of acetylcholine receptors (AChR) in normal and myasthenic human muscle.
Lecky BR; Morgan-Hughes JA
Ann N Y Acad Sci; 1981; 377():61-76. PubMed ID: 6951488
[No Abstract] [Full Text] [Related]
7. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.
Almon RR; Andrew CG; Appel SH
Science; 1974 Oct; 186(4158):55-7. PubMed ID: 4421998
[TBL] [Abstract][Full Text] [Related]
8. An electrophysiological study of the effects of D-tubocurarine, atropine, and alpha-bungarotoxin on the cholinergic receptor in innervated and chronically denervated mammalian skeletal muscles.
Lapa AJ; Albuquerque EX; Daly J
Exp Neurol; 1974 May; 43(2):375-98. PubMed ID: 4826975
[No Abstract] [Full Text] [Related]
9. Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle.
Reiness CG; Weinberg CB; Hall ZW
Nature; 1978 Jul; 274(5666):68-70. PubMed ID: 661996
[No Abstract] [Full Text] [Related]
10. Desensitization to acetylcholine at motor end plates in normal humans, patients with myasthenia gravis, and experimental models of myasthenia gravis.
Pagala MK; Namba T; Grob D
Ann N Y Acad Sci; 1981; 377():567-82. PubMed ID: 6951485
[TBL] [Abstract][Full Text] [Related]
11. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical properties of junctional and extrajunctional acetylcholine receptor.
Dwyer DS; Bradley RJ; Furner RL; Kemp GE
Brain Res; 1981 Jul; 217(1):23-40. PubMed ID: 6167329
[TBL] [Abstract][Full Text] [Related]
13. Denervation increases the degradation rate of acetylcholine receptors at end-plates in vivo and in vitro.
Bevan S; Steinbach JH
J Physiol; 1983 Mar; 336():159-77. PubMed ID: 6875905
[TBL] [Abstract][Full Text] [Related]
14. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
Vincent A; Cull-Candy SG; Newsom-Davis J; Trautmann A; Molenaar PC; Polak RL
Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological effects of myasthenic serum factors studied in mouse muscle.
Lerrick AJ; Wray D; Vincent A; Newsom-Davis J
Ann Neurol; 1983 Feb; 13(2):186-91. PubMed ID: 6830177
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural studies on the acetylcholine receptor at motor end plates of normal and pathologic muscles.
Porter CW; Barnard EA
Ann N Y Acad Sci; 1976; 274():85-107. PubMed ID: 786117
[TBL] [Abstract][Full Text] [Related]
17. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
[TBL] [Abstract][Full Text] [Related]
18. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
[No Abstract] [Full Text] [Related]
19. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.
Fambrough DM; Drachman DB; Satyamurti S
Science; 1973 Oct; 182(4109):293-5. PubMed ID: 4742736
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis animal model: quantitative analysis of the efficiency of pre- and postjunctional regions of intercostal muscles in rabbits immunized with Torpedo acetylcholine receptor.
Albuquerque EX; Eldefrawi AT; Oliveira AC; Copio DS; Eldefrawi ME
Exp Neurol; 1979 Oct; 66(1):109-22. PubMed ID: 225189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
